*Result*: ELLIPSIS: robust quantification of splicing in scRNA-seq.
Cancers (Basel). 2022 Jan 17;14(2):. (PMID: 35053605)
Nucleic Acids Res. 2022 Jan 7;50(D1):D287-D294. (PMID: 34403477)
Nat Commun. 2023 Mar 3;14(1):1230. (PMID: 36869033)
Nat Biotechnol. 2020 Jun;38(6):708-714. (PMID: 32518404)
Genome Biol. 2021 Aug 27;22(1):251. (PMID: 34452629)
Front Cell Neurosci. 2014 Nov 13;8:373. (PMID: 25431548)
BMC Bioinformatics. 2020 Sep 14;21(1):402. (PMID: 32928110)
Nucleic Acids Res. 2018 Sep 28;46(17):9106-9118. (PMID: 29901772)
Nat Protoc. 2014 Jan;9(1):171-81. (PMID: 24385147)
Science. 2016 Apr 29;352(6285):600-4. (PMID: 27126046)
Biomedicines. 2022 Jan 10;10(1):. (PMID: 35052820)
Front Mol Biosci. 2021 Nov 23;8:726902. (PMID: 34888349)
Nat Biotechnol. 2010 May;28(5):511-5. (PMID: 20436464)
Nat Commun. 2019 Jun 13;10(1):2611. (PMID: 31197158)
J Neurosurg. 2019 Apr 26;132(5):1465-1472. (PMID: 31026822)
Cell Genom. 2022 Dec 30;3(1):100244. (PMID: 36777183)
Cell. 2022 Aug 4;185(16):2899-2917.e31. (PMID: 35914528)
Nat Genet. 2000 May;25(1):25-9. (PMID: 10802651)
Nat Methods. 2010 Dec;7(12):1009-15. (PMID: 21057496)
Nat Commun. 2022 Feb 28;13(1):1084. (PMID: 35228538)
Nat Biotechnol. 2022 Oct;40(10):1452-1457. (PMID: 35637418)
BMC Biol. 2023 Oct 20;21(1):220. (PMID: 37858135)
Cell Rep. 2017 Oct 31;21(5):1399-1410. (PMID: 29091775)
Nat Genet. 2018 Jan;50(1):151-158. (PMID: 29229983)
Nature. 2020 Feb;578(7793):129-136. (PMID: 32025019)
Int J Mol Sci. 2019 Apr 26;20(9):. (PMID: 31027366)
Nature. 2022 Aug;608(7922):353-359. (PMID: 35922509)
Genome Biol. 2021 May 25;22(1):163. (PMID: 34034771)
Nucleic Acids Res. 2013 Jan;41(Database issue):D125-31. (PMID: 23118479)
Nat Biotechnol. 2024 Feb;42(2):293-304. (PMID: 37231261)
Cell. 2017 Nov 30;171(6):1316-1325.e12. (PMID: 29129375)
Front Immunol. 2024 Jun 20;15:1422113. (PMID: 38966643)
Cancers (Basel). 2022 Mar 04;14(5):. (PMID: 35267626)
Elife. 2016 Mar 25;5:. (PMID: 27015110)
Cold Spring Harb Perspect Biol. 2017 Apr 3;9(4):. (PMID: 28096261)
Genetics. 2023 May 4;224(1):. (PMID: 36866529)
Bioinformatics. 2015 Sep 1;31(17):2778-84. (PMID: 25926345)
Mol Biol Cell. 2018 Oct 15;29(21):2509-2515. (PMID: 30325290)
F1000Res. 2021 May 11;10:374. (PMID: 36762203)
Nat Methods. 2017 Apr;14(4):417-419. (PMID: 28263959)
Genome Res. 2022 Jul 27;32(7):1385-1397. (PMID: 35858747)
Anal Cell Pathol (Amst). 2020 Jan 31;2020:9274016. (PMID: 32089990)
*Further Information*
*Motivation: Alternative splicing is a tightly regulated biological process, that due to its cell type specific behavior, calls for analysis at the single cell level. However, quantifying differential splicing in scRNA-seq is challenging due to low and uneven coverage. Hereto, we developed ELLIPSIS, a tool for robust quantification of splicing in scRNA-seq that leverages locally observed read coverage with conservation of flow and intra-cell type similarity properties. Additionally, it is also able to quantify splicing in novel splicing events, which is extremely important in cancer cells where lots of novel splicing events occur.
Results: Application of ELLIPSIS to simulated data proves that our method is able to robustly estimate Percent Spliced In values in simulated data, and allows to reliably detect differential splicing between cell types. Using ELLIPSIS on glioblastoma scRNA-seq data, we identified genes that are differentially spliced between cancer cells in the tumor core and infiltrating cancer cells found in peripheral tissue. These genes showed to play a role in a.o. cell migration and motility, cell projection organization, and neuron projection guidance.
Availability and Implementation: ELLIPSIS quantification tool: https://github.com/MarchalLab/ELLIPSIS.git.
(© The Author(s) 2025. Published by Oxford University Press.)*